The Necessity of Bone Densitometry for Patients Taking Selective Serotonin Reuptake Inhibitors.
10.11005/jbm.2013.20.2.95
- Author:
Ki Yong AN
1
;
Woo Jin SHIN
;
Kyu Jung LEE
Author Information
1. Department of Orthopedic Surgery, Gwangju Veterans Hospital, Gwangju, Korea. neolimp@naver.com
- Publication Type:Original Article
- Keywords:
Osteoporosis;
Prevalence;
Serotonin uptake inhibitors
- MeSH:
Bone Density;
Densitometry*;
Diagnosis;
Hospitals, Veterans;
Humans;
Osteoporosis;
Prevalence;
Risk Factors;
Serotonin Uptake Inhibitors*
- From:Journal of Bone Metabolism
2013;20(2):95-98
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: To analyze the necessity of bone densitometry for patients long-term taking selective serotonin reuptake inhibitors (SSRI) over a long period of time, which is one of the risk factors of osteoporosis. METHODS: We selected patients from 5 veterans hospitals who took SSRI for more than 2 months while taking bone densitometry on a regular basis. RESULTS: Of the 85 patients from a total of 5 veterans hospitals taking SSRI for more than two months, only 34 patients were under diagnosis and treatment measures of osteoporosis through checking each person's bone mineral density. CONCLUSIONS: It is necessary for patients taking SSRI to check bone density on a regular basis.
